Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 3

2(22.2%)

Phase 4

1(11.1%)

9Total

N/A(6)

Phase 3(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07172451Phase 4Recruiting

Gelaspan vs Crystalloid Therapy in Sepsis

Role: collaborator

NCT06047964Not ApplicableActive Not Recruiting

SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis

Role: lead

NCT04240444Not ApplicableCompleted

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Role: lead

NCT05516446Not ApplicableUnknown

Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent

Role: collaborator

NCT04309708Not ApplicableCompleted

Efficacy and Safety Assessment for a New UV-protected Pump Infusion Line in Intravenous Infusion Therapy

Role: lead

NCT03951272Not ApplicableUnknown

The Efficacy and Safety of Lyoplant® Onlay in Repairing Cerebral Dura Mater

Role: lead

NCT03625830Not ApplicableUnknown

The Efficacy and Safety of SeQuent® Please in the Treatment of Small Vessel Disease (SVD) Patient

Role: lead

NCT03624205Unknown

The Safety and Efficacy of SeQuent® Please in Real World Chinese Coronary Instent Restenosis Patients

Role: lead

NCT01622075Phase 3Completed

A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent

Role: lead

NCT00506246Phase 3Completed

Efficacy and Safety Study of Two Propofol Formulations

Role: collaborator

All 10 trials loaded